These publications were authored or co-authored by Quest Diagnostics staff.
RNA interference characterization of proteins discovered by proteomic analysis of pancreatic cancer reveals function in cell growth and survival.Authors: Lee CN, Heidbrink JL, McKinnon K, Bushman V, Olsen H, Fitzhugh W, Li A, Van OK, He T, Ruben SM, Moore PA.
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.Authors: Lee TS, Kantarjian H, Ma W, Yeh CH, Giles F, Albitar M.
PLoS One. 2011;6:e23396.
Mol Genet Metab. 2011;103:92-95.
Circ Cardiovasc Genet. 2011;4:565-573.
Methods Mol Biol. 2011;719:219-234.
Specialties: Pathology, Laboratory Medicine
Cerebrovasc Dis. 2012;33:80-85.
Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.Authors: Ma W, Giles F, Zhang X, Wang X, Zhang Z, Lee TS, Yeh CH, Albitar M.
Int J Lab Hematol. 2011;33:326-331.
Diagn Mol Pathol. 2011;20:34-39.
Leuk Res. 2011;35:526-533.